Stem Cell Therapy Market Size to Surpass USD 921.12 Million with CAGR of 17.3% by 2030, Share, Growth, Demand, Global Trends and Competitive Outlook
February 23, 2023 03:35 ET
|
Data Bridge Market Research
MELBOURNE, Feb. 23, 2023 (GLOBE NEWSWIRE) -- Data Bridge Market Research completed a qualitative study titled "Stem Cell Therapy Market" with 100+ market data tables, pie charts, graphs, and figures...
Calidi Biotherapeutics and First Light Acquisition Group (FLAG) Announce Merger Agreement to Create a Publicly Listed, Clinical-Stage Biotechnology Company Utilizing Stem Cell-Based Platforms to Revolutionize Oncolytic Virotherapies
January 09, 2023 10:33 ET
|
First Light Acquisition Group; Calidi Biotherapeutics, Inc.
-Total gross proceeds from transaction, before payment of transaction expenses, expected to be up to $82 million assuming no redemptions, combining a possible PIPE financing of up to $40 million and...
UM171 cell therapy demonstrates improved outcomes compared to cord and matched unrelated donor peripheral blood transplants in real-world setting
December 12, 2022 08:25 ET
|
ExCellThera
MONTRÉAL, Dec. 12, 2022 (GLOBE NEWSWIRE) -- ExCellThera Inc. (ExCellThera), a world leader in blood stem cell expansion and rejuvenation, announced today findings from a safety and efficacy...
With 7.3% of CAGR, Bioreactors Market to Gain $5.1 Billion Revenue by 2027 | The Insight Partners
November 22, 2022 07:08 ET
|
The Insight Partners
New York, Nov. 22, 2022 (GLOBE NEWSWIRE) -- According to The Insight Partners latest study titled "Bioreactors Market Size, Share, Growth, Trends and Forecast to 2027– COVID-19 Impact and Global...
Global Stem Cell Therapy Market Size to grow USD 1027 Million by 2030 | CAGR of 17%
November 17, 2022 12:00 ET
|
SPHERICAL INSIGHTS LLP
New York, United States , Nov. 17, 2022 (GLOBE NEWSWIRE) -- The Global Stem Cell Market Size to grow from USD 250 million in 2021 to USD 1,027 million by 2030, at a Compound Annual Growth Rate...
ExCellThera announces 100th patient treated with UM171-expanded cell therapy
November 08, 2022 08:35 ET
|
ExCellThera
MONTREAL, Nov. 08, 2022 (GLOBE NEWSWIRE) -- ExCellThera Inc. (ExCellThera), a world leader in blood stem cell expansion and rejuvenation, announced today that its proprietary ECT-001 Cell Therapy...
Cell Therapy Manufacturing Market is expected to reach a valuation of US$ 13.9 Billion by the end of 2032, at a CAGR of 14.2% from 2022-2032 | Future Market Insights, Inc.
September 05, 2022 09:00 ET
|
Future Market Insights Global and Consulting Pvt. Ltd.
NEWARK, Del, Sept. 05, 2022 (GLOBE NEWSWIRE) -- As per Future Market Insights’ latest industry analysis, valuation of the global cell therapy manufacturing market was around US$ 3.3 Bn in 2021, and...
Seraxis Announces Appointment of Chief Medical Officer, Dr. Paul Strumph
August 30, 2022 06:45 ET
|
Seraxis, Inc.
GERMANTOWN, Md., Aug. 30, 2022 (GLOBE NEWSWIRE) -- The regenerative medicine company Seraxis Inc. today announced the appointment of Paul Strumph, M.D. as Chief Medical Officer. Dr. Strumph is an...
Stem Cell Manufacturing Market Worth USD 21 Billion by 2030 at 11.2% CAGR - Report by Market Research Future (MRFR)
June 30, 2022 06:27 ET
|
Market Research Future
New York, USA, June 30, 2022 (GLOBE NEWSWIRE) -- Stem Cell Manufacturing Market Overview According to a Comprehensive Research Report by Market Research Future (MRFR), “Stem Cell...
ExCellThera announces submission of Drug Master File for UM171
June 17, 2022 08:05 ET
|
ExCellThera
MONTRÉAL, June 17, 2022 (GLOBE NEWSWIRE) -- ExCellThera Inc. (ExCellThera), an advanced clinical-stage biotechnology company delivering molecules and bioengineering solutions to expand and...